NCT01923181 Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01885208 Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01866748 Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01766245 A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes Status COMPLETED Phase PHASE1
NCT01720446 Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01686945 Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01619345 Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01572753 Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01324505 Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01272973 Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00851773 Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects Status COMPLETED Phase PHASE1
NCT00833716 Effect of Renal Impairment on the Pharmacokinetics of NN9535 Status COMPLETED Phase PHASE1
NCT00813020 A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00696657 A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide Status COMPLETED Phase PHASE2